A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184-Reference-Cited by-同舟云学术

A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184

Published:2010-02 Issue:2 Volume:116 Page:163-167
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Mackay Helen J.,Tinker Anna,Winquist Eric,Thomas Gillian,Swenerton Kenneth,Oza Amit,Sederias Joana,Ivy Percy,Eisenhauer Elizabeth A.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference38 articles.

1. Cervical cancer;Waggoner;Lancet,2003

2. National Cancer Institute. Cervical cancer (PDQ®): Treatment. 2005. http://www.cancer.gov/cancertopics/pdq/treatment/cervical/HealthProfessional/page4.

3. Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study;Bonomi;J. Clin. Oncol.,1985

4. Chemotherapy for cervix cancer [Review];Omura;Semin. Oncol.,1994

5. Paclitaxel has moderate activity in squamous cervix cancer: a Gynecologic Oncology Group study;McGuire;J. Clin. Oncol.,1996

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and pharmacodynamics of angiogenesis inhibitors used to treat cervical cancer: current and future;Expert Opinion on Drug Metabolism & Toxicology;2024-09-09

2. Pharmacotherapy for cervical cancer: current standard of care and new perspectives;Expert Opinion on Pharmacotherapy;2024-08-12

3. Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer;Medical Oncology;2024-07-10

4. Potential inhibitors of VEGFR1, VEGFR2, and VEGFR3 developed through Deep Learning for the treatment of Cervical Cancer;Scientific Reports;2024-06-10

5. Treatment Strategies for Cervical Cancer in Older Women: Challenges and Advancements;Current Cancer Therapy Reviews;2024-03